Lamb Weston Holdings, Inc. (FRA:0L5)

Intra-Cellular Therapies Revenue

In the fiscal year ending May 25, 2025, Lamb Weston Holdings had annual revenue of $6.45B USD, down -0.25%. Lamb Weston Holdings had revenue of $1.68B in the quarter ending May 25, 2025, with 3.96% growth.

• Revenue: $6.45B
• Revenue Growth: -0.25%
• P/S Ratio: 1.19
• Revenue / Employee: $602.93K
• Employees: 10,700
• Market Cap: 6.76B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 25, 2025	6.45B	-16.30M	-0.25%
May 26, 2024	6.47B	1.12B	20.88%
May 28, 2023	5.35B	1.25B	30.54%
May 29, 2022	4.10B	428.00M	11.66%
May 30, 2021	3.67B	-121.50M	-3.20%